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Serotonin (5-HT) is a neurotransmitter that plays an important role in neuronal plasticity.
Variations in the levels of 5-HT at the synaptic cleft, expression or dysfunction of
5-HT receptors may alter brain development and predispose to various mental diseases.
Here, we review the transduction pathways described in various cell types transfected
with recombinant 5-HT1A receptor (5-HT1AR), specially contrasting with those findings
obtained in neuronal cells. The 5-HT1AR is detected in early stages of neural development
and is located in the soma, dendrites and spines of hippocampal neurons. The 5-HT1AR
differs from other 5-HT receptors because it is coupled to different pathways, depending
on the targeted cell. The signaling pathway associated with this receptor is determined
by Gα isoforms and some cascades involve βγ signaling. The activity of 5-HT1AR usually
promotes a reduction in neuronal excitability and firing, provokes a variation in cAMP
and Ca2+ , levels which may be linked to specific types of behavior and cognition.
Furthermore, evidence indicates that 5-HT1AR induces neuritogesis and synapse
formation, probably by modulation of the neuronal cytoskeleton through MAPK and
phosphoinositide-3-kinase (PI3K)-Akt signaling pathways. Advances in understanding
the actions of 5-HT1AR and its association with different signaling pathways in the central
nervous system will reveal their pivotal role in health and disease.
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INTRODUCTION
Serotonin (5-HT) is a chemical mediator, synthesized from tryptophan, that has been maintained
throughout evolution. In mammals, in addition to its role as a neurotransmitter, 5-HT has
been described as a regulator of neuronal connectivity during development by modulating cell
migration and cytoarchitecture (Lauder, 1993). Indeed, abnormal levels of 5-HT result in aberrant
morphology and wiring of the nervous system in mammals (for review see Gaspar et al., 2003).
Alterations in neural circuits observed in adults may be related to dysfunction in the actions
and/or levels of 5-HT during key stages of development, which may predispose juvenile and adult
individuals to various mental diseases (Hornung, 2003). Thus, a number of factors that can modify
5-HT levels during pregnancy may alter brain development: changes in nutrition affecting the
availability of tryptophan (Serfaty et al., 2008), challenges to stressors (Papaioannou et al., 2002),
infections (Winter et al., 2009) and antidepressant drugs that act as serotonin reuptake inhibitors
(SSRIs; Xu et al., 2004).
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The serotonin receptors have been classified as 5-HT1A−F,
5-HT2A−C; 5-HT3, 5-HT4, 5-HT5, 5-HT6 and 5-HT7. Unlike
the 5-HT3 receptor that is ionotropic (Mattson et al., 2004),
the remaining receptors are coupled to different G proteins
(Albert and Tiberi, 2001). Given the diversity of 5-HT receptors,
it has been difficult to define their precise role on brain
development, either individually or in combination with other
receptors. Nonetheless, immunohistochemical studies show
that these receptors are expressed early during embryonic
development and are dynamically regulated postnatally,
suggesting a pivotal role during brain development (Gaspar
et al., 2003). In the present article, we will extensively review
the existing literature on 5-HT1A receptor (5-HT1AR)-
mediated signaling in neurons, mainly in the hippocampus
brain area. It is important to highlight that many of the
signaling pathways associated with the 5-HT1AR have been
derived from studies in non-neuronal cells, revealing the
important contribution of this review on the neuroscience
field.
5-HT1AR DISTRIBUTION IN THE
HIPPOCAMPUS DURING DEVELOPMENT
AND ADULTHOOD
The 5-HT1AR transcript is detected in the rodent fetal brain
at stage E12, achieves a maximum level at E15 and then
progressively reduces its expression to low levels before
birth (E20; Hillion et al., 1993). The expression of 5-HT1AR
coincides with the migration of young neurons to their
appropriate neuronal stratum during embryonic development
(Patel and Zhou, 2005). In the hippocampus, neurons begin
to express the 5-HT1AR at around E16; just 1–2 days after
mitosis accomplishment and prior to migration to the laminar
layer (Patel and Zhou, 2005). In developing hippocampus
at E18, this receptor is detected in interneurons located
in stratum radiatum and stratum oriens (Patel and Zhou,
2005). Furthermore, 5-HT1AR is also detected in the soma
and emerging neurites of young neurons, which have just
reached the stratum pyramidale (Patel and Zhou, 2005). We
have recently detected 5-HT1AR mRNA and protein at 2 and
3 days in vitro (DIV) in hippocampal primary cultures obtained
from E18 fetuses (Rojas et al., 2014). In addition, during
postnatal development, the 5-HT1AR is redistributed from
the soma to the basal and apical dendrites; a phenomenon
observed in both pyramidal and granule neurons of the
hippocampus (Patel and Zhou, 2005). Interestingly, in brain
neurons, the Ypt1p interacting factor homolog B (Yif1B) has
been identified as a vesicular membrane-bound scaffolding
protein which interacts directly with the C-terminal domain of
the rat 5-HT1AR to mediate the intracellular trafficking of this
receptor towards dendrites (Carrel et al., 2008). Additionally,
the somato-dendritic distribution of 5-HT1AR detected early in
the hippocampus prevails in adult animals; also displaying a
location at dendritic spines (Riad et al., 2000). Furthermore,
the somatic-dendritic redistribution of this receptor may be
associated with the differential actions of 5-HT; i.e., in the
soma, receptor activation may be associated with the regulation
of cell growth by controlling gene expression and neuronal
excitability; but in dendrites, this receptor may regulate
neuronal morphology (Patel and Zhou, 2005). In adult animals,
interestingly, the 5-HT1AR is detected in the subgranular layer
of the dentate gyrus and its activation increases the proliferation
of granule cell precursors in this hippocampal area (Gould,
1999).
5-HT1AR ACTIVATION MODULATES
NEURONAL EXCITABILITY AND
RESPONSIVENESS TO
NEUROTRANSMITTERS
In both neurons and brain tissue, few signal transduction
cascades associated with the activity of the 5-HT receptors have
been described. Serotonergic fibers spread diffusely in brain
and often lack direct synaptic contacts; however the release of
5-HT may play an important role in the fine tuning of neuronal
communication in the hippocampus (Vizi and Kiss, 1998). The
activity of the 5-HT1AR allows a modulatory effect by changing
neuronal firing. Electrophysiological studies have shown that
stimulation of 5-HT1AR in serotonergic neurons of the raphe
nuclei (autoreceptor) induces cell hyperpolarization and a
reduction in 5-HT release (Polter and Li, 2010). Furthermore,
the activation of 5-HT1AR exerts hyperpolarizing effects in
hippocampal neurons (Dong et al., 1997; Salgado-Commissariat
and Alkadhi, 1997; Tokarski et al., 2002; Tada et al., 2004).
Nonetheless, in ventral hippocampus, 5-HT1AR activity produces
an indirect excitatory response through the inhibition of
GABAergic interneuron activity induced by hyperpolarization
(Schmitz et al., 1995b).
On the other hand, glutamate receptor-mediated
transmission between CA3 and CA1 pyramidal neurons can be
depressed by 5-HT1AR activity (Costa et al., 2012). The change
in cell polarity mediated by 5-HT1AR occurs by activation of
Gαi/o and subsequent release of the βγ complex, which triggers
the gating of inward rectifying potassium channels (GIRK;
Figure 1). Interestingly, in contrast to the desensitization of
5-HT1A autoreceptors (Riad et al., 2001), the persistent activation
of 5-HT1ARs coupled to GIRK in the hippocampus does not
promote its internalization (Dong et al., 1998). According to
this evidence, it seems that the desensitization of 5-HT1ARs
depends on the cell type in which the receptors are expressed.
Furthermore, it was described that 5-HT1AR might reduce
excitatory transmission in rat CA1 hippocampal area by a
putative presynaptic mechanism that reduces Ca2+ entry and
glutamate release (Schmitz et al., 1995a).
5-HT1A RECEPTOR ACTIVATION
MEDIATES OPPOSING EFFECTS ON
ADENYLATE CYCLASE ACTIVITY IN
NON-NEURONAL AND NEURONAL CELLS
The use of transfection techniques of the human 5-HT1AR
in different cell lines has allowed further insight about the
association of this receptor with specific G protein transducers,
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FIGURE 1 | Transductional pathways associated with 5-HT1A receptor (5-HT1AR) activation in neuronal and neuronal cell lines. In neurons, receptor
activation releases βγ and promotes an increase in AC II activity, with concomitant increase in AMPc levels and PKA activation. The βγ complex also participates in
the activation of the phosphoinositide-3-kinase (PI3K)-Akt pathway, which triggers an increase in phospho-ERK levels. Moreover, the PI3K-Akt-GSK-3β pathway
increases mitochondrial transport in axons. Additionally, stimulation of the receptor increases Ca2+ levels, which also contributes to the activation of PKCα and ERK,
reducing caspase-3 levels. Release of the βγ complex also activates a K+ rectifier channel (GIRK), allowing cell hyperpolarization. According to that described in cell
lines, the association between receptor activity and the reduction in AC I activity is only valid in the case of the autoreceptor, such as in neurons of the raphe nucleus.
and related signaling pathways. In the HEK293 cell line, the
activation of 5-HT1AR activates Gαi/o, leading to a reduction in
cAMP levels through inhibition of adenylyl cyclase (AC) type I
(Albert et al., 1999; Figure 2). However, when HEK293 cells
were co-transfected with the 5-HT1AR along with AC type II,
the agonist (8OH-DPAT) increased cAMP levels, an effect
mediated by the Gβγ complex, which stimulates enzyme
activity (Albert et al., 1999). Similar effects were observed
in co-transfection experiments with pituitary cell lines (Liu
et al., 1999). Interestingly, co-transfection with AC type II
and Gαi2, but not Gαi1, Gαi3, or Gαo, resulted in an agonist-
independent increase in basal cAMP levels, suggesting that the
Gαi2 isoform promotes constitutive activation of the receptor
(Albert et al., 1999). In contrast, the presence of both Gαi2
and Gαi3 results in reduced cAMP levels, suggesting that the
action of Gαi3 predominates over that of Gαi2 (Liu et al., 1999;
Figure 2).
In vivo microdialysis experiments have shown that systemic
administration of 8OH-DPAT, an agonist that displays high
affinity for 5-HT1AR (0.65 nM) in comparison to 5-HT7R
(35 nM; Sprouse et al., 2004), increases the efflux of cAMP in the
ventral hippocampus (Cadogan et al., 1994). The interpretation
of this in vivo study is highly complex because the systemic
administration of 8OH-DPAT may involve the participation
of 5-HT1AR located in serotonergic neurons of the raphe
nucleus (autoreceptors), which may diminish the liberation of
5-HT in targeted areas. Thus, a reduction of 5-HT1AR activity
in several structures, including the hippocampus, may occur
associated to reduced αi coupling to AC type I, with the
consequent enhancement in cAMP effux (Figure 1). On the
other hand, it is probable that 8OH-DPAT not only involves
5-HT1AR, but also the 5-HT7R, which activates AC (Ruat et al.,
1993). Nonetheless, the study of Cadogan et al. (1994) also
showed that cAMP efflux induced by 8OH-DPAT is blocked
by pre-treatment with WAY-100135, an antagonist with high
selectivity for 5-HT1AR (IC50 = 15 nM) over 5-HT1B, 1C, α1 and
α2 adrenoceptor and D2 receptors (IC50 > 1000 nM; Fletcher
et al., 1993). On the other hand, some direct determinations of
5-HT1AR activity have been conducted in mammalian guinea
pig and rat hippocampal membranes. These studies revealed
that 5-HT and 8OH-DPAT stimulate the production of cAMP,
although the latter compound showed a reduced efficacy,
suggesting the contribution of other receptors such as 5HT7R
(De Vivo and Maayani, 1986). In contrast, the same study
demonstrated that 8OH-DPAT reduces Forskolin-stimulated
cAMP production through a receptor with pharmacological
characteristics of 5-HT1AR (De Vivo and Maayani, 1986).
Furthermore, prolonged exposure of cultured hippocampal
neurons to 8OH-DPAT did not significantly affect 5-HT1AR-
induced inhibition of cAMP production, indicating that this
receptor does not desensitize in this model (Varrault et al.,
1991).
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FIGURE 2 | Transductional pathways associated with the activation of the 5-HT1AR overexpressed in non-neuronal cell lines. Signaling pathways of the
5-HT1A-R in CHO (cells derived from Chinese hamster ovary) and HEK293 (human embryonic kidney) cells are described. Activation of the receptor reduces cAMP
levels through the inhibition of AC I, with a subsequent decrease in PKA activity; an effect mediated by Gαi/0. In contrast, co-expression of the receptor with AC II
promotes an increase in the activity of this enzyme, increasing cAMP levels and PKA activation; effect mediated by βγ. The release of βγ after the activation of the
receptor promotes ERK phosphorylation through two pathways, which involve the Ras-Raf-MEK and phosphatidylcholine-specific phospholipase C (PC-PLC)
proteins. Moreover, the increase in ERK phosphorylation after the activation of the receptor promotes a reduction in caspase-3 activity; an effect mediated by the
activation of the nuclear factor κB (NF-κB) transcription factor. Additionally, the activation of the 5-HT1AR also activates the PI3K-Akt pathway, which participates in
ERK phosphorylation.
According to discussed evidences, the signaling pathway
associated with 5-HT1AR is probably determined by the precise
Gα isoform existing in cells, even though the presence of other
G protein transducers may redirect signal transduction to other
existing pathways. Furthermore, considering that AC type II is
highly expressed in soma and dendrites of hippocampal neurons
(Baker et al., 1999), it is feasible that in restricted areas of
hippocampus, the 5-HT1AR activates AC type II through the
Gβγ complex (Figure 1), similarly to the transfected HEK cell
(Figure 2).
5-HT1AR AND MAPK ACTIVATION
OCCURS THROUGH INTRICATE
PATHWAYS IN NON-NEURONAL CELL
MODELS
Studies in Chinese hamster ovary (CHO) cells transfected
with the human 5-HT1AR have demonstrated that stimulation
with 5-HT and the 5-HT1AR agonist, 8OH-DPAT, promotes
the phosphorylation of ERK (Cowen et al., 1996; Hsiung
et al., 2005). This response was shown to be blocked by
pertussis toxin and thus, corroborated the participation of
Gαi and Gαo (Cowen et al., 1996; Garnovskaya et al., 1996;
Hsiung et al., 2005). 5-HT1A-mediated MAPK activation
in CHO cells is blocked by specific 5-HT1AR antagonists
(Cowen et al., 1996; Errico et al., 2001) or dominant
negative mutants of GRK, β-arrestin and dynamin; proteins
involved in agonist-induced receptor endocytosis (Della Rocca
et al., 1999). Additionally, in CHO-1A-27, the increase in
phospho-ERK1/2 levels induced by 5-HT is prevented by
the addition of an intracellular calcium chelator (BAPTA)
and by phenothiazine, an inhibitor of calmodulin (CaM),
revealing the participation of Ca2+/CaM (Della Rocca et al.,
1999; Figure 2). Furthermore, ERK1/2 activation is sensitive
to the inhibition of Src type kinases (Garnovskaya et al.,
1998). In CHO cells, ERK activation mediated by 5-HT1AR
involves βγ subunit as transducers (Garnovskaya et al., 1996).
The release of βγ subunits induced by 5-HT1AR activity
triggers the formation of a multimolecular complex, including
Grb2, p46Shc, p52Shc, which is required for activation of
the exchange factor Son-of-sevenless (SOS), which in turn
activates the Ras/Raf/MEK pathway (Garnovskaya et al., 1996;
Figure 2). Likewise, inhibition of CaM reduces the activity
of both Src tyrosine kinase and the small GTP-ase Ras,
but not of Raf kinase and mitogen-activated protein kinase
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(MEK; Della Rocca et al., 1999). These evidences suggest
that the Ca2+/CaM complex is required downstream of Ras
activation, but upstream of Raf and MEK activation (Della
Rocca et al., 1999; Figure 2). It has been established that the
third loop of the 5-HT1AR contains two binding sites for CaM
(Turner et al., 2004); interaction that in HEK293 cells, mediates
CaM-induced clathrin-mediated endocytosis of 5-HT1AR, a
step in the activation of MEK and ERK (Della Rocca
et al., 1999; Figure 2). Thus, the mechanism by which
5-HT1AR activates the RAS–MAPK pathway through Gβγ
is still uncertain; it seems to involve recruitment of GRK
to phosphorylate the receptor, and both β-arrestin-mediated
internalization and Src-like kinases activation upon receptor
internalization.
In CHO cells, 5-HT1AR-induced activation of ERK involves
the participation of phosphatidylcholine-specific phospholipase
C (PC-PLC) and phosphoinositide-3-kinase (PI3K; Cowen et al.,
1996; Garnovskaya et al., 1996, 1998; Hsiung et al., 2005). In
this same cell type, studies have indicated that 5-HT1AR agonists
prevent activation of caspase-3 induced by serum deprivation,
phenomenon associated with the activation of PI3K-PKB (Akt)
and ERK pathways (Hsiung et al., 2005; Figure 2). Furthermore,
this same study showed that PI3K-Akt activity promotes
degradation of IKBα, a protein that inhibits Nuclear Factor κB
(NF-κB) transcriptional activity by its retention in the cytosol,
with the subsequent NF-κB translocation to the nucleus (Hsiung
et al., 2005; Figure 2).
5-HT1AR AND MAPK ENGAGEMENT IN
NEURONAL CELLS: POSSIBLE
IMPLICATION IN NEURONAL
MORPHOLOGY
Studies performed in the HN2-5 immortalized hippocampal
cell line, which overexpresses the 5-HT1AR, indicated
that stimulation with 8OH-DPAT slowly increases the
phosphorylation of ERK, through a mechanism that involves
Gαi/o protein and PI3K activation (Adayev et al., 1999; Figure 1).
Additionally, in HN2-5 cells the 5-HT1AR activates PLCβ and
increases Ca2+ levels, leading to PKCα and ERK activation and
inhibition of caspase-3 activation and apoptosis (Adayev et al.,
1999, 2003; Figure 1).
Activation of ERK1/2 and the PI3K/PKB signaling pathways
not only regulate neuronal differentiation and survival, but
also control neurite outgrowth and branching by modulating
the reorganization of the cytoskeleton (Kim et al., 2004;
Jaworski et al., 2005; Kumar et al., 2005). Some studies have
shown that 5-HT depletion in the early postnatal period (P3)
causes a reduction in dendrite length and spine density of
hippocampal granule neurons and these effects are prevented
by the administration of a 5-HT1AR agonist (Yan et al., 1997).
In line with these results, stimulation of the hippocampal
5-HT1AR in organotypic cultures of hippocampi from mice
at postnatal period (P15)—that coincides with the peak of
synaptogenesis—increases dendritic spine density and synapse
formation through sequential activation of ERK1/2 and PKC
(Mogha et al., 2012); however, the precise mechanism has
not been characterized. In vitro studies have indicated that
5-HT1AR activation induces an increase in both the number
and length of neurites in mouse neuroblastoma (Fricker et al.,
2005). Our recently published study using rat hippocampal
primary cultures demonstrated that stimulation of 5-HT1AR at
2 DIV promotes the growth of secondary neurites (Rojas et al.,
2014). The molecular mechanisms underlying the regulation
of neurite outgrowth mediated by 5-HT1AR remains to be
elucidated.
Besides, in vivo pharmacological blockade of 5-HT1AR with
WAY-100635 during 3–5 weeks of postnatal development,
significantly increases branch points of the apical dendritic tree
in CA1 neurons (Ferreira et al., 2010). Additionally, in a primary
culture of mouse hippocampus (5 DIV), stimulation with 5-HT
was described to promote depolymerization of filamentous actin
in cone growth, an effect observed in WT mice, but not in KO
mice for 5-HT1AR (Ferreira et al., 2010). Therefore, it has been
suggested that 5-HT1AR regulates actin dynamics and restricts
dendritic growth and thus, modulates neuronal connectivity
during a certain period of development (Ferreira et al., 2010).
Considering the evidence as a whole, 5HT1AR promotes synapse
formation but restricts dendrite arborization.
ACTIVATION OF THE 5-HT1AR IN
NON-NEURONAL AND NEURONAL CELLS
AND ITS RELATIONSHIP WITH THE
PI3K-AKT-GSK-3β PATHWAY
Systemic administration of 8OH-DPAT in mice increases
phosphorylation at Thr308 and in a lesser degree, Ser473 of
Akt in hippocampus (Polter et al., 2012). These changes were
correlated with an increase in the inactivating phosphorylation
of GSK-3β (9Ser; Leemhuis et al., 2004; Polter and Li,
2011), effects which are attenuated by the specific 5-HT1AR
antagonist, WAY-100635. The interpretation of in vivo studies
is complicated because the systemic administration may involve
both the activation of autoreceptors located on serotonergic
neurons in the raphe nucleus, or heteroreceptors in other
structures different from that of the hippocampus. Therefore,
it is possible that changes in the phosphorylation of GSK-3β
are product of the contribution of indirect effects of 5-HT
receptors located in different brain areas. Interestingly, GSK-3β
activity regulates the activity of several microtubule-associated
proteins (MAPs) and during development, may direct axon
growth and guidance, a process which requires microtubule
dynamics (Garrido et al., 2007). The causal link between
the activation of 5-HT1AR and phosphorylation of Akt and
GSK-3β has not been fully documented in cultured neurons.
In hippocampal neurons of 5–7 DIV, 5CT, 8OH-DPAT and
5-HT increase phosphorylation of Akt at Ser473 (Cowen et al.,
2005). Additionally, in a more mature hippocampal culture
(17 DIV), stimulation with 5-HT or 8OH-DPAT increases
phosphorylation of Akt at Ser473, and rises phospho-GSK3β
(Chen et al., 2007). Interestingly, 5-HT1AR has been reported
to promote mitochondrial movement in axons of hippocampal
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neurons at 17 DIV, and this effect is mediated by the
inhibition of GSK-3β promoted by Akt (Chen et al., 2007;
Figure 1).
Although the previous evidences indicate a relationship
between the activation of 5-HT1AR and Akt phosphorylation,
it is still unclear whether this depends on the activity of PI3K
in a similar manner to that described in CHO cells (Hsiung
et al., 2005; Figure 2). However, in hippocampal tissue, the
5-HT1AR transduces via Gαi/0 and therefore, it is likely that
the βγ complex not only regulates neuronal activity through
GIRK, but also activates PI3K, stimulating the phosphorylation
of Akt, as has been shown in non-neuronal cell lines. It will
be important to determine—in neuronal cultures—the causal
relation between PI3K and Akt activation, and its downstream
effectors, according to the particular 5-HT1AR distribution
in neurons. Furthermore, in rat cortical primary cultures,
it has been reported that 5-HT1AR activation promotes a
destabilization of microtubules, reducing the transport of vesicles
that contain the NR2B subunits of the NMDA receptor to
dendrites and therefore, reducing channel conductance (Yuen
et al., 2005). These evidences indicate that 5-HT1AR can regulate
microtubule reorganization and both organelle and receptor
trafficking.
5-HT1AR FORMS COMPLEX WITH GPCRs:
A MECHANISM TO MODULATE ITS
SIGNALING
Several reports have described that a wide variety of GPCRs
expressed in recombinant cell systems may form homodimers
and heterodimers. Some evidences suggest that GPCR
dimer/oligomer species may differ in several aspects with
the non-associated receptors, including ligand binding affinity
and pharmacological profile, G-protein coupling, receptor
trafficking and desensitization (Milligan, 2007). It has been
described that 5-HT1AR constitutively forms homodimers
in transfected HEK 293 cells; however the agonist favors the
interaction of monomers, while the presence of antagonist
reduces dimer formation (Łukasiewicz et al., 2007). Interestingly,
the 5HT1AR may also form heterodimers with several GPCRs,
creating new receptor species that may display a different
behavior in comparison to individual receptors. For instance,
stimulation of cells expressing either 5-HT1AR or mu-opioid
receptors with specific agonists triggers in both cases, the
activation of MAPK, cascade which desensitizes after 30 min of
stimulation. Nonetheless, when both receptors are co-expressed,
the activation of one receptor in the 5-HT1AR/µ-opioid
heterodimer inhibits MAPK activation of the other receptor
(Cussac et al., 2012). On the other hand, biochemical studies
accomplished in neuroblastoma N1E-115 cells revealed that
5-HT1AR forms dimers and homo-oligomers, being dimers the
prevalent species at the plasma membrane (Kobe et al., 2008;
Woehler et al., 2009). Moreover, kinetics of 5-HT1AR dimer
dissociation or association into high order homo-oligomers
is not influenced by ligand binding (Kobe et al., 2008).
For instance, the specific formation of 5-HT1AR-5-HT7R
heterodimers was evidenced by co-immunoprecipitation
and Forster resonance energy transfer (FRET) approaches
in transfected N1E-115 cells with tagged-receptors (Renner
et al., 2012). Furthermore, this study indicated that when
both receptors are expressed in similar levels, the formation
of 5-HT1AR-5-HT7R species is favored in comparison to
the 5-HT1AR-5-HT1AR homodimer (Renner et al., 2012).
Functional analyses using recombinant protein expression in
Xenopus oocytes showed that co-expression of 5HT1AR and
5HT7R decreases 5-HT1AR-mediated activation of Gαi and
GIRK channel activity, without affecting 5-HT7R mediated
activation of Gs (Renner et al., 2012). This study also showed
that both receptors are endogenously expressed in cultured
hippocampal neurons and that after the knock-down of 5-
HT7R with siRNA, GIRK activity is reduced by a 5-HT1AR
agonist (Renner et al., 2012). This evidence, along with
co-immunoprecipitation of both receptors in brain lysates
(Renner et al., 2012), suggests a negative regulation of
5-HT1AR signaling driven by the presence of 5-HT7R.
Moreover, the finding that during development 5HT1AR
varies its expression and distribution (i.e., somato-dendritic
shift; Patel and Zhou, 2005) and that 5-HT7R reduces its
expression (Kobe et al., 2012), it is reasonable to think that,
in vivo, there is a variation in the proportion of heterodimeric
receptors, which may impact 5HT signaling mediated by the
5-HT1AR.
CONCLUDING REMARKS
In summary, several studies have shown the coupling of 5-HT1AR
with several signal transduction pathways in heterologous
systems and only a few of these pathways have been studied
in neuronal systems, where they are mainly associated with
neuronal development, neuronal excitability and survival.
Furthermore, it is likely that somatic receptors participate in
the maintenance of neuronal survival, control gene expression
and neuronal excitability. In contrast, those receptors located in
dendrites would be more closely related to dendritic outgrowth
and branching. Additional studies are needed to elucidate brain
region- and neuronal-specific signaling mechanisms coupled
to 5-HT1AR and their modulation by heterodimerization with
other receptors, effects which may play a pivotal role in the
actions of 5-HT during development and also, in some mood
disorders.
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